ASALYXA BIO
Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With applications across a wide array of disease areas and conditions, Asalyxa Bio's platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells.
ASALYXA BIO
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
Southfield, Michigan, United States
Country:
United States
Website Url:
http://www.asalyxabio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Aclipse Therapeutics
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Cellics Therapeutics
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tryptamine Therapeutics
Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michigan Rise
Michigan Rise investment in Seed Round - Asalyxa Bio
Biosciences Research and Commercialization Center (BRCC)
Biosciences Research and Commercialization Center (BRCC) investment in Seed Round - Asalyxa Bio
Invest Detroit Ventures
Invest Detroit Ventures investment in Seed Round - Asalyxa Bio
Research Bridge Partners
Research Bridge Partners investment in Seed Round - Asalyxa Bio
Ann Arbor SPARK
Ann Arbor SPARK investment in Seed Round - Asalyxa Bio
Woodward Angels
Woodward Angels investment in Seed Round - Asalyxa Bio
Michigan Rise
Michigan Rise investment in Seed Round - Asalyxa Bio
Official Site Inspections
http://www.asalyxabio.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Asalyxa Bio"
Asalyxa Bio - Crunchbase Company Profile & Funding
Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the …See details»
Our first portfolio company, Asalyxa Bio, has launched - Orange …
Sep 29, 2020 Asalyxa Bio was co-founded by U-M scientists and Orange Grove Bio, a New York-based venture operating company. The company’s chief scientific officer is Lola Eniola …See details»
Asalyxa - The Org
Asalyxa bio is a novel biotech innate immune system targeting platform looking to regulate immune system response to prevent severe reactions through the power of immunotherapy. …See details»
Asalyxa Bio - VentureRadar
Asalyxa Bio is drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With …See details»
Asalyxa Bio - Company Profile - Tracxn
Asalyxa Bio - Developer of neutrophil targeting drugs for Acute Respiratory Distress Syndrome and COVID-19. Raised a total funding of $2M over 1 round from 9 investors. Founded by Marc …See details»
Asalyxa Bio Update - Orange Grove Bio
Feb 23, 2021 With applications across a wide array of disease areas and conditions, Asalyxa Bio’s platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells. …See details»
Asalyxa Bio: Revenue, Worth, Valuation & Competitors 2024
About Asalyxa Bio. Asalyxa Bio is a Biotech related company founded in 2020 and based in Southfield with 5 employees an estimated revenue of $387.5K, and. It has 10 competitors …See details»
Asalyxa Bio Company Profile - Office Locations, Competitors
Asalyxa Bio has 5 employees at their 1 location and $2 m in total funding,. See insights on Asalyxa Bio including office locations, competitors, revenue, financials, executives, …See details»
Asalyxa Bio – Startups.Bio
Sep 22, 2020 Founded in 2020, Asalyxa Bio is a spinout from the University of Michigan, focused on the rapid development of a new neutrophil-targeting drug platform.Neutrophils are …See details»
Asalyxa Bio Company and Investment Profile | MAGNiTT
Asalyxa Bio has 200 funding rounds worth 200. Orange Corner Innovation Fund (OCIF) United Arab Emirates (UAE) $9.5M - $18.2M. Valuation Estimate. $100K. Amount. Undisclosed. …See details»
Asalyxa Bio 2025 Company Profile: Valuation, Funding ... - PitchBook
Asalyxa Bio General Information Description. Developer of neutrophil-targeting drugs designed to combat severe neutrophil-mediated diseases like Covid-19. The company's platform leverages …See details»
Asalyxa Bio | F6S
About Asalyxa Bio Asalyxa is focused on the rapid development of a revolutionary neutrophil-targeting drug platform. The versatility of Asalyxa’s proprietary platform allows for the direct …See details»
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio
1/23/2022. AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities …See details»
Asalyxa Bio - UM - Innovation Partnerships - University of Michigan
Asalyxa Bio is a platform company committed to the targeting of neutrophils to fight hard to treat diseases. Launch: 2020. Subscribe to Our Newsletter . 1600 Huron Pkwy, Building 520, 2nd …See details»
Asalyxa Bio — Michigan State University Research Foundation
May 18, 2022 asalyxabio.com Asalyxa Bio is focused on the novel biotech development of its neutrophil targeting platform to treat significant unmet medical needs through immunotherapySee details»
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio
AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities with the …See details»
Asalyxa Bio - Overview, News & Similar companies - ZoomInfo
Asalyxa bio is a novel biotech innate immune system targeting platform looking to regulate immune system response to prevent severe reactions throu gh the power of immunotherapy. …See details»
Asalyxa Bio Closes Seed Financing to Advance Lead Program into …
Feb 23, 2021 Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune …See details»
Research Bridge Partners' Seed Capital Investment in Asalyxa Bio ...
AUSTIN, Texas, March 9, 2021 /PRNewswire/ -- Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities with the ...See details»